FDA Approved: NEULASTA — Supplemental Application (Amgen, Inc)

View source ↗

Summary

The FDA approved a supplemental Biologics License Application for NEULASTA (pegfilgrastim) from Amgen, resulting in labeling updates approved by the agency. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Neutropenia After Autologous Hematopoietic Stem Cell Transplantation

Drugs mentioned

• NEULASTA (pegfilgrastim)

Snippet

SUPPL AP for NEULASTA (PEGFILGRASTIM)